Flexibility of small molecular CD4 mimics as HIV entry inhibitors-Reference-Cited by-同舟云学术

Flexibility of small molecular CD4 mimics as HIV entry inhibitors

Published:2018-11 Issue:21 Volume:26 Page:5664-5671
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Kobayakawa Takuya^ORCID,Ohashi Nami,Hirota Yuki,Takahashi Kohei,Yamada Yuko,Narumi Tetsuo,Yoshimura Kazuhisa,Matsushita Shuzo,Harada Shigeyoshi,Tamamura Hirokazu

Funder

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference51 articles.

1. Peptide-derived mid-sized anti-HIV agents;Ohashi,2017

2. Mid-size drugs based on peptides and peptidomimetics: A new drug category;Tamamura,2018

3. A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140;Tamamura;Biochem Biophys Res Commun,1998

4. Pharmacophore identification of a specific CXCR4 inhibitor, T140, leads to development of effective anti-HIV agents with very high selectivity indexes;Tamamura;Bioorg Med Chem Lett,2000

5. Molecular-size reduction of a potent CXCR4-chemokine antagonist using orthogonal combination of conformation- and sequence-based libraries;Fujii;Angew Chem Int Ed,2003

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications of “linkers” in fragment-based drug design;Bioorganic Chemistry;2022-10

2. Photoinduced Cascade C–N/C═O Bond Formation from Bromodifluoroalkyl Reagents, Amines, and H₂O via a Triple-Cleavage Process;Organic Letters;2022-02-22

3. Recent research results have converted gp120 binders to a therapeutic option for the treatment of HIV-1 infection. A medicinal chemistry point of view;European Journal of Medicinal Chemistry;2022-02

4. Potent leads based on CA-19L, an anti-HIV active HIV-1 capsid fragment;Bioorganic & Medicinal Chemistry;2021-01

5. Exploratory studies on CA-15L, an anti-HIV active HIV-1 capsid fragment;Bioorganic & Medicinal Chemistry;2020-06